BlackRock Health Sciences Term Trust (NYSE:BMEZ – Get Free Report) was the recipient of a significant growth in short interest in the month of October. As of October 15th, there was short interest totaling 200,900 shares, a growth of 61.1% from the September 30th total of 124,700 shares. Based on an average daily volume of 266,600 shares, the days-to-cover ratio is currently 0.8 days. Based on an average daily volume of 266,600 shares, the days-to-cover ratio is currently 0.8 days.
Institutional Inflows and Outflows
A number of large investors have recently modified their holdings of the business. Larson Financial Group LLC lifted its holdings in shares of BlackRock Health Sciences Term Trust by 51.9% during the first quarter. Larson Financial Group LLC now owns 2,050 shares of the company’s stock worth $31,000 after buying an additional 700 shares during the last quarter. Chapin Davis Inc. lifted its holdings in shares of BlackRock Health Sciences Term Trust by 3.2% during the third quarter. Chapin Davis Inc. now owns 27,605 shares of the company’s stock worth $398,000 after buying an additional 849 shares during the last quarter. Brown Lisle Cummings Inc. lifted its holdings in shares of BlackRock Health Sciences Term Trust by 1.9% during the second quarter. Brown Lisle Cummings Inc. now owns 45,112 shares of the company’s stock worth $643,000 after buying an additional 852 shares during the last quarter. Truist Financial Corp lifted its holdings in shares of BlackRock Health Sciences Term Trust by 5.9% during the second quarter. Truist Financial Corp now owns 19,645 shares of the company’s stock worth $280,000 after buying an additional 1,093 shares during the last quarter. Finally, Elequin Capital LP lifted its holdings in shares of BlackRock Health Sciences Term Trust by 20.7% during the first quarter. Elequin Capital LP now owns 7,079 shares of the company’s stock worth $105,000 after buying an additional 1,214 shares during the last quarter.
BlackRock Health Sciences Term Trust Stock Down 0.9%
Shares of BlackRock Health Sciences Term Trust stock opened at $14.87 on Tuesday. The stock has a 50 day moving average price of $14.62 and a two-hundred day moving average price of $14.39. BlackRock Health Sciences Term Trust has a 12-month low of $12.58 and a 12-month high of $16.75.
BlackRock Health Sciences Term Trust Dividend Announcement
About BlackRock Health Sciences Term Trust
BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.
Featured Stories
- Five stocks we like better than BlackRock Health Sciences Term Trust
- Short Selling – The Pros and Cons
- Semiconductor Supercycle: Why Onsemi Stock Could Double as AI and EV Growth Accelerate
- How to Calculate Options Profits
- The Best Local Butchers for Thanksgiving [2025 Survey]
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- $134M in Insider Moves: What It Might Mean for KMI, ISRG and QS
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.
